Sign In
Buy RDHL
$1.00
-0.0100 (-0.99%)
At Close: Jun 03, 2026
RedHill Biopharma to Present at the BIO Digital International Convention
07:00am, Wednesday, 09'th Jun 2021
TEL AVIV, Israel and RALEIGH, N.C., June 9, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.
RedHill completes enrollment in the global Phase 2/3 severe COVID-19 study with oral opaganib
06:38am, Tuesday, 08'th Jun 2021
RedHill Biopharma Ltd. (NASDAQ:RDHL) said it has completed enrollment and randomized the last patient in the global Phase 2/3 study with oral opaganib in patients hospitalized with severe coronavirus
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study
07:00am, Monday, 07'th Jun 2021
TEL AVIV, Israel and RALEIGH, NC, June 7, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has co
RedHill Biopharma highlights strong end to first-quarter and almost 100% enrollment in opaganib's Phase 2/3 study for COVID-19
10:26am, Tuesday, 01'st Jun 2021
RedHill Biopharma Ltd (NASDAQ:RDHL) has reported its financial results and operational highlights for the first quarter ended March 31, 2021, with the company highlighting a strong end to the first q
RedHill Biopharma Ltd.'s (RDHL) CEO Dror Ben-Asher on Q1 2021 Results - Earnings Call Transcript
03:17pm, Thursday, 27'th May 2021
RedHill Biopharma Ltd.'s (RDHL) CEO Dror Ben-Asher on Q1 2021 Results - Earnings Call Transcript
Strength Seen in Redhill Biopharma Ltd. (RDHL): Can Its 5.4% Jump Turn into More Strength?
08:16am, Thursday, 27'th May 2021
Redhill Biopharma Ltd. (RDHL) saw its shares surge in the last session with trading volume being higher than average.
RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights
07:00am, Thursday, 27'th May 2021
TEL AVIV, Israel and RALEIGH, N.C., May 27, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.
RedHill Biopharma receives two US Patent and Trademark Office Allowances for its oral pills for COVID-19, opaganib and RHB-10
04:13pm, Wednesday, 26'th May 2021
RedHill Biopharma Ltd. (NASDAQ:RDHL) has announced the receipt of two Notices of Allowance from the US Patent and Trademark Office (USPTO) covering opaganib and RHB-107 (upamostat), as methods for the
Earnings Outlook for Redhill Biopharma
10:38am, Wednesday, 26'th May 2021
Redhill Biopharma (NASDAQ:RDHL) releases its next round of earnings this Thursday, May 27. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
07:00am, Wednesday, 26'th May 2021
TEL AVIV, Israel and RALEIGH, NC, May 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced receipt of two
RedHill's Novel Late-Stage Pills Hold Promise Against COVID-19 and its Variants
08:00am, Tuesday, 25'th May 2021
Photo by Elsa Olofsson on Unsplash World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus recently said the COVID-19 pandemic's second year was on track to be its deadliest.
RedHill Biopharma Presents Analyses of Movantik Onset of Action and Symptom Improvement at DDW 2021
07:00am, Monday, 24'th May 2021
TEL AVIV, Israel and RALEIGH, N.C., May 24, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.
TEL AVIV, Israel and RALEIGH, N.C., May 21, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.
RedHill Biopharma to Host First Quarter 2021 Financial Results and Operational Highlights Webcast on May 27, 2021
07:00am, Thursday, 20'th May 2021
TEL AVIV, Israel and RALEIGH, N.C., May 20, 2021 /PRNewswire/ -- RedHill Biopharma Ltd.
Could These 2 Exciting COVID Stocks be 10-Baggers?
06:15am, Sunday, 11'th Apr 2021
They're approaching the treatment-race finish line.
